49884-105-11 : NDC 2026 Code

49884-105-11 : Entecavir ( Entecavir )

Additionally :

You can get information about “49884-105-11” NDC code in 49884-105-11 in HTML format

HTML | 49884-105-11 in TXT (Plain Text) format

TXT | 49884-105-11 in PDF (Portable Document Format)

PDF | 49884-105-11 in JSON format

JSON formats.

NDC Code : 49884-105-11 – XML Data Format

                    
<?xml version="1.0" encoding="UTF-8"?>
<NDC>
	<NDCCode>
		49884-105-11
	</NDCCode>
	<PackageDescription>
		1 BOTTLE in 1 CARTON (49884-105-11)  &gt; 30 TABLET, FILM COATED in 1 BOTTLE
	</PackageDescription>
	<NDC11Code>
		49884-0105-11
	</NDC11Code>
	<ProductNDC>
		49884-105
	</ProductNDC>
	<ProductTypeName>
		HUMAN PRESCRIPTION DRUG
	</ProductTypeName>
	<ProprietaryName>
		Entecavir
	</ProprietaryName>
	<ProprietaryNameSuffix/>
	<NonProprietaryName>
		Entecavir
	</NonProprietaryName>
	<DosageFormName>
		TABLET, FILM COATED
	</DosageFormName>
	<RouteName>
		ORAL
	</RouteName>
	<StartMarketingDate>
		20140818
	</StartMarketingDate>
	<EndMarketingDate>
		20170831
	</EndMarketingDate>
	<MarketingCategoryName>
		NDA AUTHORIZED GENERIC
	</MarketingCategoryName>
	<ApplicationNumber>
		NDA021797
	</ApplicationNumber>
	<LabelerName>
		Par Pharmaceutical Inc.
	</LabelerName>
	<SubstanceName>
		ENTECAVIR
	</SubstanceName>
	<StrengthNumber>
		1
	</StrengthNumber>
	<StrengthUnit>
		mg/1
	</StrengthUnit>
	<Pharm_Classes>
		Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]
	</Pharm_Classes>
	<DEASchedule/>
	<Status>
		Deprecated
	</Status>
	<LastUpdate>
		2017-09-01
	</LastUpdate>
	<PackageNdcExcludeFlag/>
	<ProductNdcExcludeFlag/>
	<ListingRecordCertifiedThrough/>
	<StartMarketingDatePackage/>
	<EndMarketingDatePackage/>
	<SamplePackage/>
</NDC>

NDC XML XSD Schema

                    
<xs:schema attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema">
  <xs:element name="NDC">
    <xs:complexType>
      <xs:sequence>
        <xs:element type="xs:string" name="NDCCode"/>
        <xs:element type="xs:string" name="PackageDescription"/>
        <xs:element type="xs:string" name="NDC11Code"/>
        <xs:element type="xs:string" name="ProductNDC"/>
        <xs:element type="xs:string" name="ProductTypeName"/>
        <xs:element type="xs:string" name="ProprietaryName"/>
        <xs:element type="xs:string" name="ProprietaryNameSuffix"/>
        <xs:element type="xs:string" name="NonProprietaryName"/>
        <xs:element type="xs:string" name="DosageFormName"/>
        <xs:element type="xs:string" name="RouteName"/>
        <xs:element type="xs:string" name="StartMarketingDate"/>
        <xs:element type="xs:string" name="EndMarketingDate"/>
        <xs:element type="xs:string" name="MarketingCategoryName"/>
        <xs:element type="xs:string" name="ApplicationNumber"/>
        <xs:element type="xs:string" name="LabelerName"/>
        <xs:element type="xs:string" name="SubstanceName"/>
        <xs:element type="xs:string" name="StrengthNumber"/>
        <xs:element type="xs:string" name="StrengthUnit"/>
        <xs:element type="xs:string" name="Pharm_Classes"/>
        <xs:element type="xs:string" name="DEASchedule"/>
        <xs:element type="xs:string" name="Status"/>
        <xs:element type="xs:string" name="LastUpdate"/>
        <xs:element type="xs:string" name="PackageNdcExcludeFlag"/>
        <xs:element type="xs:string" name="ProductNdcExcludeFlag"/>
        <xs:element type="xs:string" name="ListingRecordCertifiedThrough"/>
        <xs:element type="xs:string" name="StartMarketingDatePackage"/>
        <xs:element type="xs:string" name="EndMarketingDatePackage"/>
        <xs:element type="xs:string" name="SamplePackage"/>
      </xs:sequence>
    </xs:complexType>
  </xs:element>
</xs:schema>